Literature DB >> 170242

A new gas lesion syndrome in man, induced by "isobaric gas counterdiffusion".

C J Lambertsen, J Idicula.   

Abstract

Normal men have been found to develop pruritus and gas bubble lesions in the skin, and disruption of vestibular function, when breathing nitrogen or neon with oxygen while surrounded by helium at increased ambient pressure. This phenomenon, which occurs at stable ambient pressures, at 1 or many ATA, has been designated the "isobaric gas counterdiffusion syndrome." In a series of analyses and experiments in vivo and in vitro the cause of the syndrome has been established as due to gas accumulation and development of gas bubbles in tissues as a result of differences in selective diffusivities, for various respired and ambient gases, in the tissue substances between capillary blood and the surrounding atmosphere. The phenomenon here described in man is an initial stage of a process shown later in animals to progress to continuous, massive, lethal, intravascular gas embolization.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170242     DOI: 10.1152/jappl.1975.39.3.434

Source DB:  PubMed          Journal:  J Appl Physiol        ISSN: 0021-8987            Impact factor:   3.531


  3 in total

1.  Kinetics of isobaric counterdiffusion.

Authors:  G Karreman; C J Lambertsen
Journal:  Bull Math Biol       Date:  1977       Impact factor: 1.758

2.  Effect of isobaric breathing gas shifts from air to heliox mixtures on resolution of air bubbles in lipid and aqueous tissues of recompressed rats.

Authors:  O Hyldegaard; D Kerem; Y Melamed
Journal:  Eur J Appl Physiol       Date:  2011-02-12       Impact factor: 3.078

3.  Comparison of treatment recompression tables for neurologic decompression illness in swine model.

Authors:  W Rainey Johnson; Nicholas G Roney; Hanbing Zhou; Geoffrey E Ciarlone; Brian T Williams; William T Green; Richard T Mahon; Hugh M Dainer; Brett B Hart; Aaron A Hall
Journal:  PLoS One       Date:  2022-10-05       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.